JPRN-UMIN000007545已完成2 期
Feasibility study of neoadjuvant mFOLFOX6 plus cetuximab in patients with resectable liver limited metastases from colorectal cancer harboring KRAS wild type - FANTASTIC trial
ational Cancer Center Hospital East0 个研究点目标入组 20 人开始时间: 2012年3月21日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)Synchronous multiple malignancy or metachronous multiple malignancy within 5 years disease free interval (2)Symptomatic brain metastases (3)Severe infectious disease (4)Interstitial lung disease or pulmonary fibrosis (5)Comorbidity or history of heart failure (6)Sensory alteration or paresthesia interfering with function (7)Severe comorbidity (renal failure, liver failure, hypertension, etc) (8)History of severe allergy (9)Women who are unwilling to avoid pregnancy. Women who are pregnant or breastfeeding. Women with a positive pregnancy test
研究者
相似试验
已完成
2 期
Phase II study of neoadjuvant mFOLFOX6 (+ cetuximab) in patients with resectable pelvic recurrences after rectal cancer surgeryRecurrent rectal cancerJPRN-UMIN000009583ational Cancer Center Hospital East33
已完成
2 期
Multicancer Phase II study of mFOLFOX6 as Neoadjuvant chemotherapy for T3 or T4 Stage II / III rectal cancerRectal CancerJPRN-UMIN000006583Tokyo Women's Medical University Hospital50
已完成
2 期
The feasibility and efficacy of neoadjuvant FOLFOXIRI followed by laparoscopic surgery for locally advaned rectal cancer: A phase II studycolorectal cancerJPRN-UMIN000026575Osaka Medical College Hospital58
未知
不适用
Feasibility study of neoadjuvant chemotheray mFOLFOX6 for resectable liver metastases of colorectal cancerscolorectal cancersJPRN-UMIN000000961Dept. Surgey Kyoto University Hospital27
已完成
4 期
A feasibility study of adjuvant therapy with FOLFOX plus Ca/Mg for the patient with colorectal cancerColorectal CancerJPRN-UMIN000003708Kyushu Study group of Clinical Cancer48